Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Chen, Runzhen, Liu, Chen, Zhou, Peng, Li, Jiannan, Zhou, Jinying, Wang, Ying, Zhao, Xiaoxiao, Chen, Yi, Yan, Shaodi, Song, Li, Zhao, Hanjun, Yan, Hongbing
Materyal Türü: Online Makale Metin
Dil:English
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2022
Konular:
Pharmacology
Online Erişim:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Benzer Materyaller